Relationships among the Dosage of Erythropoiesis-Stimulating Agents, Erythropoietin Resistance Index, and Mortality in Maintenance Hemodialysis Patients

Pan, S; Zhao, DL; Li, P; Sun, XF; Zhou, JH; Song, KK; Wang, Y; Miao, LN; Ni, ZH; Lin, HL; Liu, FY; Li, Y; He, YN; Wang, NS; Wang, CL; Zhang, AH; Chen, MH; Yang, XP; Deng, YY; Shao, FM; Fu, SX; Fang, JA; Cai, GY; Chen, XM

Cai, GY; Chen, XM (通讯作者)，Chinese Peoples Liberat Army Gen Hosp, PLA Med Coll, Natl Clin Res Ctr Kidney Dis, Dept Nephrol,Chinese PLA Inst Nephrol,State Key L, Beijing, Peoples R China.

BLOOD PURIFICATION, 2022; 51 (2): 171

Abstract

Background: Erythropoiesis-stimulating agents (ESAs) constitute an important treatment option for anemia in hemodialysis (HD) patients. We investigate......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索